Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1B In-vivo Study of KSP/QRH Heptapeptide Dimer for Detection of Neoplasia in the Esophagus

NCT03852576 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03852576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03852576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1B In-vivo Study of KSP/QRH Heptapeptide Dimer for Detection of Neoplasia in the Esophagus
Lead sponsor
University of Michigan
Phase
Phase 1
Overall status
Terminated
Start date
May 9, 2019
Completion date
November 18, 2020
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus